About the Journal

Journal of Advanced Pharmaceutical Science and Technology (JAPST) is a peer reviewed, open access journal dedicated to pharmaceutical development and technology. We publish research that advances formulation, delivery systems, analytical validation, stability and pharmacokinetics, materials for drug delivery, and manufacturing and quality engineering across the lab-to-scale pipeline.

A clear mandate for pharmaceutical science and technology

JAPST is built for researchers who convert scientific insight into pharmaceutical outcomes. Our mission is to accelerate the translation of pharmaceutical innovation from bench scale experimentation to robust, scalable, and compliant manufacturing. We prioritize studies that show how a formulation, delivery platform, or analytical strategy improves therapeutic performance, stability, or manufacturability.

This is a journal for pharmaceutical scientists, formulation chemists, process engineers, analytical teams, and translational researchers who want a focused outlet for rigorous, technology driven work. Papers that are purely clinical pharmacotherapy or purely biological without a pharmaceutics or technology contribution are not a fit for JAPST.

Journal at a glance

ISSN: 2328-0182 | DOI prefix: 10.14302/issn.2328-0182 | License: CC BY 4.0 | Open access publishing

Scope and focus areas

JAPST publishes across the pharmaceutical development lifecycle, with emphasis on technical evidence and measurable deliverables. Core domains include:

We prioritize manuscripts that deliver

• Formulation strategies supported by characterization, release behavior, and stability evidence.
• Delivery performance data that connects design choices to bioavailability or therapeutic outcomes.
• Validated analytical methods with clear applicability to quality control or regulatory submission.
• Manufacturing or scale up studies that prove process robustness and repeatability.
• Biopharmaceutics or PK analyses that link formulation variables to in vivo performance.
• Materials or excipient innovations backed by safety, compatibility, and performance data.
• Translational manufacturability that supports clinical or commercial readiness.

Article types and research formats

JAPST welcomes original research, systematic reviews, mini reviews, methods and protocols, short communications, and technology focused perspectives. We also consider translational studies that pair formulation or process changes with meaningful performance data.

• Original research that provides full experimental validation and reproducible methods.
• Analytical and PAT studies that improve quality control or regulatory readiness.
• Process development, scale up, or QbD studies tied to product performance.
• Delivery system design and comparative evaluations with clear decision criteria.
• Computational pharmaceutics when supported by experimental or manufacturing outcomes.

Editorial leadership and peer review

Our editorial board includes formulation scientists, analytical chemists, biopharmaceutics specialists, and process engineering leaders with global expertise. Each submission is matched to reviewers who understand the technical demands of pharmaceutical development.

Reviews focus on clarity, reproducibility, and technological value so authors receive actionable feedback that improves manuscript quality and impact.

• Scope fit screening ensures only relevant work enters review.
• Method validation and data integrity checks support reliable conclusions.
• Manufacturability and translational relevance are assessed where appropriate.

Publication standards and integrity

JAPST evaluates submissions for novelty, technical rigor, and reproducibility. Our editorial screening ensures that manuscripts meet scope and quality expectations before peer review, reducing time to decision and improving reviewer focus.

We follow international publishing ethics, requiring transparency around study design, data integrity, and conflicts of interest. Authors are expected to provide ethics approvals where applicable and to disclose funding sources and author contributions.

• Originality screening and plagiarism checks prior to review.
• Methodological clarity to support replication and validation.
• Data availability statements that enhance trust and citation potential.

Editorial policies and author rights

JAPST maintains clear editorial policies to protect research integrity and author rights. Our editors apply consistent criteria across submissions, and all reviewer feedback is handled with confidentiality and professionalism. We also encourage transparent reporting so readers can assess reproducibility and practical impact.

Authors retain rights under the CC BY 4.0 license, which allows broad reuse with attribution and supports funder open access mandates. For details, review the Editorial Policies and Copyright License pages.

Open access visibility and impact

As an open access journal, JAPST ensures that your research is accessible without subscription barriers. This increases readership across academic, clinical, and industry communities and supports real world application of your findings. Articles are published with DOIs and metadata that support discoverability, citation, and long term indexing.

We work with authors to present clear, professional research narratives that stand up to peer review and serve as credible references for formulation development, regulatory filing, and product strategy teams.

Indexing and visibility improve when manuscripts include standardized metadata, robust keywords, and clear methodological reporting. Our production team supports these requirements to help authors reach the widest possible audience. This visibility supports citation growth and collaboration across sectors.

Data transparency and archiving

We encourage data sharing when appropriate to improve reproducibility and trust. Manuscripts should include a clear data availability statement and describe how readers can access supporting datasets, protocols, or code.

For data policy details and archiving permissions, review the Data Archiving Permissions page.

Article processing charges and waivers

JAPST operates under an open access model that supports rapid publication and global accessibility. Article processing charges help cover editorial assessment, peer review management, production, and long term hosting.

We consider waiver and discount requests for authors with demonstrated need. See the Article Processing Charges page for current rates and waiver guidance.

Special issues and collaborations

We publish focused special issues that bring together research teams working on emerging pharmaceutical technologies. Guest editors propose themes aligned with JAPST scope, and selected issues receive dedicated promotion.

If you have a proposal for a special issue or want to join an ongoing call, visit the Proposed Special Issue and Ongoing Special Issue pages.

How to submit

Authors may submit through the online submission system or by email. Before submission, review the Instructions for Author for formatting and documentation requirements.

• Online submission: Manuscript submission form
• Email submission: [email protected]

Why authors choose JAPST

• Focused scope for pharmaceutical development and technology, not broad clinical medicine.
• Editorial screening that protects reviewer time and speeds up decisions.
• Professional copyediting and production with rapid online publication.
• Open access visibility that reaches industry, regulators, and academic partners.
• Dedicated editorial support from submission to final proofs.

Who publishes in JAPST

Our authors include academic researchers, pharmaceutical R&D teams, process engineers, and analytical scientists who work on practical development challenges. Many submissions report applied formulation studies, scale up approaches, or analytical validation work that supports real world manufacturing and regulatory needs. We value manuscripts that articulate a clear development gap and provide reproducible methods that other teams can adopt.

We also welcome early career researchers and cross functional collaborations that produce clear pharmaceutics deliverables, especially those focused on translational readiness or quality engineering across the development lifecycle.

Ready to publish with JAPST?

Share your pharmaceutical science and technology research with a global, open access audience.